Skip to content

Correlation Between Aqueous Protein Level and Clinical Grading of Flare and Flaremetry.

Correlation Between Aqueous Protein Level and Clinical Grading of Flare and Flaremetry.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01905579
Enrollment
20
Registered
2013-07-23
Start date
2013-03-31
Completion date
2013-08-31
Last updated
2014-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveitis

Keywords

flaremetry, aqueous proteins, clinical grading, Compare flaremetry readings with the protein content of the aqueous, Compare flaremetry readings with clinical grading of flare

Brief summary

The purpose of this study is to compare flaremetry readings with the protein content of the aqueous humor and the clinical grading of flare.

Detailed description

A total of 20 patients will be included. 10 patients with uveitis and 10 control patients scheduled for phacoemulsification. Each patient will undego complete ophthalmic examination and clinical biomicroscopic grading of the anterior chamber flare applying the SUN working group grading system. Aqueous specimens will be obtained by anterior chamber paracentesis for protein analysis. Each Patient will undego paracentesis and 0.2 ml of aqueous will be obtained. The aqueous sample will be stored at -70°C until the time of analysis for protein content. Objective assessment of flare will be done.

Interventions

PROCEDUREParacentesis of the anterior chamber

Aqueous humor parenthesis for quantitative protein analysis in patients with and without uveitis.

Sponsors

The Eye Center and The Eye Foundation for Research in Ophthalmology
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 10 patients with uveitis with cataract * 10 patients without uveitis with cataract * Inactive inflammation for at least 3 months

Exclusion criteria

* Infectious uveitis * endophthalmitis * cases with corneal scar

Design outcomes

Primary

MeasureTime frameDescription
compare flaremetry readings with the protein content of the aqueous humorone monthCompare flaremetry readings with the protein content of the aqueous and the clinical grading.

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026